Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis. Observations from the TIMI 14 trial - de Lemos, JA; Gibson, CM; Antman, EM (Am Heart J, 2001)
et al.